Founded by Fathia Methnani nearly two decades ago, the consultancy built a strong reputation advising pharma and biotech companies on aseptic processes, cleanroom behaviour, and microbial risk mitigation. Fathia will remain involved during the transition to ensure a smooth handover of client relationships and internal knowledge.
The acquisition allows Progress to offer clients broader expertise while reinforcing its presence in sterile manufacturing support. For clients of Methnani & Associates, the integration into Progress brings access to a wider team of consultants, deeper regulatory insight, and streamlined project execution.
The merger also reflects a broader trend in the life sciences sector where specialised firms are joining forces to offer more comprehensive services across development and manufacturing lifecycles.
Read the full announcement to see how this strengthens microbiology support for your operations.
Leiden Bio Science Park welcomes Eli Lilly, strengthening The Netherlands' position in life sciences with a $3 billion facility. Eli Lilly and Company announced plans to build a...
From the Van Nelle Factory to BioPartner 5, from heritage to future, from start-up to innovative lab design agency. After an inspiring and innovative seven-year start at the...
Starting Friday, November 14 at 4:00 p.m., two temporary closures (in place for the duration of the Plesmanlaan project, until approximately Q3 2027) will be implemented for...